EV/EBITDA
-4.09
-0.03-0.74%
Wed, 27 Nov 2024 23:36:55 GMT
Summary:
Cardiol Therapeutics EV/EBITDA is currently -4.09, with a fall of -0.03 (-0.74%) during the most recent trading day. Over the past year, it has dropped by -2.83 (-224.60%). CRDL EV/EBITDA is now -989.13% below its all-time high of 0.46.CRDL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDL EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | -0.7% |
1 m1 month | +15.0% |
3 m3 months | +14.8% |
6 m6 months | +35.0% |
ytdytd | -232.5% |
1 y1 year | -224.6% |
5 y5 years | +16.5% |
CRDL EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | -4.01 | -2.0% | -5.41 | +24.4% |
3 m | 3 months | -3.94 | -3.8% | -6.66 | +38.6% |
6 m | 6 months | -3.94 | -3.8% | -8.40 | +51.3% |
1 y | 1 year | -1.16 | -252.6% | -8.40 | +51.3% |
3 y | 3 years | 0.46 | -989.1% | -8.40 | +51.3% |
5 y | 5 years | 0.46 | -989.1% | -8.71 | +53.0% |
alltime | all time | 0.46 | -989.1% | -11.35 | +64.0% |
Cardiol Therapeutics EV/EBITDA History
Date | Value |
---|---|
2024 | -4.09(+232.5%) |
2023 | -1.23(-451.4%) |
2022 | 0.35(-121.9%) |
Date | Value |
---|---|
2021 | -1.60(-59.5%) |
2020 | -3.95(-53.4%) |
2019 | -8.47 |
FAQ
- What is Cardiol Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Cardiol Therapeutics?
- What is CRDL EV/EBITDA year-to-date change?
- What is Cardiol Therapeutics EV/EBITDA year-on-year change?
What is Cardiol Therapeutics EV/EBITDA?
The current EV/EBITDA of CRDL is -4.09
What is the all time high EV/EBITDA for Cardiol Therapeutics?
Cardiol Therapeutics all-time high EV/EBITDA is 0.46
What is CRDL EV/EBITDA year-to-date change?
Cardiol Therapeutics EV/EBITDA has changed by -2.86 (-232.52%) since the beginning of the year
What is Cardiol Therapeutics EV/EBITDA year-on-year change?
Over the past year, CRDL EV/EBITDA has changed by -2.83 (-224.60%)